Enhabit Inc

Enhabit, Inc. functions as an investment holding company. It provides home health and hospice services. Its Home Health services give patients access to the care they deserve in the comfort of their own homes. From disease and injury management to recovery from surgery, clinicians help patients confidently achieve their healthcare goals. The firm's Hospice services place importance on the comfort of every patient living with a terminal illness. The company was founded in 2014 and is headquartered in Dallas, TX.

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Enhabit Inc reports solid Q4 performance amidst strategic changes

Enhabit Inc showcased solid financial performance in Q4 2022, with notable strengths in strategic changes and operational effectiveness.
Challenges include revenue impact from payer shifts and cost pressures, while opportunities lie in revenue growth and optimizing operational efficiency.
The company's focus on acquisitions, patient care optimization, and disciplined growth strategies will be key for future success.
Enhabit's performance, strengths, challenges, and opportunities position it for continued growth and operational excellence in the Home Health and Hospice sectors.

Enhabit Inc reports mixed Q1 results, focuses on growth opportunities

Enhabit Inc saw mixed performance with revenue decline but strong EBITDA guidance.
Challenges include lower patient days in hospice and rising G&A costs.
Opportunities lie in expanding patient accessibility and driving incremental volume.
Overall, Enhabit is focused on independent operation amidst industry consolidation.

Enhabit Inc reports strong growth amidst Medicare Advantage challenges

Enhabit Inc showcased strong performance in non-episodic admissions and cash flow generation, while facing challenges from Medicare Advantage shifts.
The company's strengths lie in recruitment efforts, successful negotiations, and strategic focus on hospice management.
Challenges include maintaining relationships amidst market shifts and diversifying patient mix in hospice.
Opportunities exist in addressing challenges through recruitment strategies, strategic alternatives, and adapting to market changes.

Enhabit reports Q3 revenue decline but secures covenant relief

Enhabit Inc's Q3 2023 performance reflected revenue and EBITDA declines, but strategic initiatives and financial management strength support future growth prospects.
The company's recognition for workplace culture and operational focus are key strengths, while challenges in admissions and financial metrics require targeted solutions.
Opportunities in Medicare pricing, volume growth, and hospice segment trends offer avenues for Enhabit to drive revenue and operational improvements in the coming quarters.

Enhabit Inc reports Q4 results, eyes growth through strategic initiatives

Enhabit Inc's Q4 2023 performance showed mixed results with revenue decline but growth in key segments, setting the stage for strategic initiatives in 2024.
The company's focus on payer innovation contracts, Medicare Advantage transitions, and hospice case management highlights a path for future growth and operational excellence.
While facing challenges in contract predictability and regulatory uncertainties, Enhabit's strengths in contract quality and operational performance present opportunities for sustained success.
Enhabit's financial outlook for 2024 includes a focus on revenue growth, cost management, and strategic expansion, positioning the company for continued progress and profitability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Enhabit, Inc. functions as an investment holding company. It operates under the Home Health and Hospice segments. The Home Health segment provides home health services via home nursing services to adult patients in need of care. The Hospice segment offers hospice agencies. The company was founded in 2014 and is headquartered in Dallas, TX.

DALLAS--( BUSINESS WIRE )--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, announced today its recent placements in Fortune's “30 Best Large Workplaces in Healthcare” awards as well as Modern Healthcare's “Best Places to Work in Healthcare” awards series, highlighting Enhabit's commitment to its people.

Enhabit Home Health & Hospice Receives Two “Best Place to Work” Awards in Health Care

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Credit Suisse 31st Annual Healthcare Conference in Palos Verdes, California on Nov. 8, 2022.

Enhabit announces participation in upcoming Credit Suisse 31st Annual Healthcare Conference

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2022.

Enhabit Reports Third Quarter Financial Results

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the third quarter ended Sept. 30, 2022, after the market closes on Nov. 1, 2022, and host a webcast and conference call on Nov. 2, 2022. Individuals who would like to participate in the conference call should dial in 15 minutes before the scheduled start time. Nov. 2, 2022 10:00 a.m. Eastern Toll-free: 888-660-6150 International: 929-203-0843 C

Enhabit Home Health & Hospice Announces Date of 2022 Third Quarter Earnings Call

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, announced today the acquisition of Caring Hearts Hospice, a locally owned and operated hospice agency in Texas. Effective Oct. 1, 2022, this acquisition adds four hospice locations to Enhabit's existing presence in Texas, allowing Enhabit to expand its nationwide footprint. “We are excited to welcome the Caring Hearts Hospice employees to Enhabit,” says Enhabit President and CEO Barb Jacobsmeyer. “T

Enhabit Home Health & Hospice Acquires Caring Hearts Hospice

DALLAS , Aug. 23, 2022 /PRNewswire/ -- Enhabit Home Health & Hospice (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the following events: Jefferies Nashville Bus Tour on Aug. 31, 2022 2022 Wells Fargo Healthcare Conference in Boston on Sept. 8, 2022 Enhabit's President and Chief Executive Officer Barbara Jacobsmeyer and Chief Financial Officer Crissy Carlisle will participate in a fireside chat on Thursday, Sept.

Enhabit Home Health & Hospice announces participation in upcoming investor meetings

Company to host a conference call tomorrow, Aug. 2, 2022 at 11 AM EDT DALLAS , Aug. 1, 2022 /PRNewswire/ -- Enhabit Home Health & Hospice (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2022. "It has been a very busy and rewarding quarter as we worked hard in preparation of becoming an independent, publicly traded company on July 1," Enhabit's President and Chief Executive Officer, Barb Jacobsmeyer said.

Enhabit Reports Second Quarter Financial Results

Enhabit appears to be significantly undervalued compared to peers in the same line of business. On an absolute basis, Enhabit looks cheap compared to its future cash flows.

Enhabit: A Chip Off The Old Stock

DALLAS , July 7, 2022 /PRNewswire/ -- Enhabit Home Health & Hospice (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2022, after the market closes on Aug. 1, 2022. The Company will host its first investor conference call as an independent, publicly traded company to discuss its results for the quarter at 11 a.m.

Enhabit Home Health & Hospice announces date of 2022 second quarter earnings call

Encompass Health

Enhabit also announces two new appointments to its board of directors DALLAS , July 1, 2022 /PRNewswire/ -- Enhabit Home Health & Hospice, a leading national home health and hospice provider, today announces it is now an independent, publicly traded company following the completion of its spin-off from Encompass Health Corporation. Enhabit will begin trading regular way on the New York Stock Exchange this morning, July 1, 2022, under the ticker symbol "EHAB.

Enhabit Home Health & Hospice Completes Spin-off from Encompass Health

News for Enhabit Inc Stock (EHAB)